Pelthos Therapeutics Statistics
Total Valuation
PTHS has a market cap or net worth of $75.19 million. The enterprise value is $64.47 million.
Important Dates
The next estimated earnings date is Friday, March 27, 2026, before market open.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTHS has 3.24 million shares outstanding. The number of shares has increased by 170.72% in one year.
| Current Share Class | 3.24M |
| Shares Outstanding | 3.24M |
| Shares Change (YoY) | +170.72% |
| Shares Change (QoQ) | +377.97% |
| Owned by Insiders (%) | 5.57% |
| Owned by Institutions (%) | 26.49% |
| Float | 1.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.15 |
| Forward PS | 1.63 |
| PB Ratio | 1.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.01 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.66 |
Financial Efficiency
Return on equity (ROE) is -83.00% and return on invested capital (ROIC) is -42.40%.
| Return on Equity (ROE) | -83.00% |
| Return on Assets (ROA) | -20.64% |
| Return on Invested Capital (ROIC) | -42.40% |
| Return on Capital Employed (ROCE) | -20.88% |
| Weighted Average Cost of Capital (WACC) | 27.68% |
| Revenue Per Employee | $673,273 |
| Profits Per Employee | -$2.14M |
| Employee Count | 11 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -465,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.91% in the last 52 weeks. The beta is 4.07, so PTHS's price volatility has been higher than the market average.
| Beta (5Y) | 4.07 |
| 52-Week Price Change | +35.91% |
| 50-Day Moving Average | 24.48 |
| 200-Day Moving Average | 23.21 |
| Relative Strength Index (RSI) | 50.29 |
| Average Volume (20 Days) | 5,939 |
Short Selling Information
The latest short interest is 75,690, so 2.34% of the outstanding shares have been sold short.
| Short Interest | 75,690 |
| Short Previous Month | n/a |
| Short % of Shares Out | 2.34% |
| Short % of Float | 5.82% |
| Short Ratio (days to cover) | 4.01 |
Income Statement
In the last 12 months, PTHS had revenue of $7.41 million and -$23.58 million in losses. Loss per share was -$19.07.
| Revenue | 7.41M |
| Gross Profit | 5.09M |
| Operating Income | -21.23M |
| Pretax Income | -24.05M |
| Net Income | -23.58M |
| EBITDA | n/a |
| EBIT | -21.23M |
| Loss Per Share | -$19.07 |
Full Income StatementBalance Sheet
The company has $14.20 million in cash and $3.48 million in debt, with a net cash position of $10.72 million or $3.31 per share.
| Cash & Cash Equivalents | 14.20M |
| Total Debt | 3.48M |
| Net Cash | 10.72M |
| Net Cash Per Share | $3.31 |
| Equity (Book Value) | 58.25M |
| Book Value Per Share | 18.85 |
| Working Capital | 24.99M |
Full Balance SheetCash Flow
| Operating Cash Flow | -17.01M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | 68.73% |
| Operating Margin | -286.65% |
| Pretax Margin | -324.69% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | -286.65% |
| FCF Margin | n/a |
Dividends & Yields
PTHS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -170.72% |
| Shareholder Yield | -170.72% |
| Earnings Yield | -31.36% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PTHS is $56.75, which is 144.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $56.75 |
| Price Target Difference | 144.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 2, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PTHS has an Altman Z-Score of -0.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.57 |
| Piotroski F-Score | 2 |
